tiprankstipranks
Altamira Therapeutics (CYTO)
NASDAQ:CYTO
US Market
Holding CYTO?
Track your performance easily

Altamira Therapeutics (CYTO) Technical Analysis

598 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Altamira Therapeutics’s (CYTO) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Altamira Therapeutics is a Buy.
Altamira Therapeutics’s (CYTO) 20-Day exponential moving average is 0.40, while Altamira Therapeutics’s (CYTO) share price is $0.3, making it a Sell.
Altamira Therapeutics’s (CYTO) 50-Day exponential moving average is 0.49, while Altamira Therapeutics’s (CYTO) share price is $0.3, making it a Sell.

Altamira Therapeutics (CYTO) Pivot Points

Dec 22, 2024, 10:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.13
0.21
0.26
0.34
0.39
0.47
0.52
Fibonacci
0.21
0.26
0.29
0.34
0.39
0.42
0.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Altamira Therapeutics (CYTO) Moving Averages

Dec 22, 2024, 10:28 PM
Period
Simple
Exponential
MA5
0.33Sell
0.29Sell
MA10
0.40Sell
0.36Sell
MA20
0.42Sell
0.40Sell
MA50
0.47Sell
0.49Sell
MA100
0.66Sell
0.68Sell
MA200
1.09Sell
1.11Sell
Altamira Therapeutics’s (CYTO) 10-Day exponential moving average is 0.36, while Altamira Therapeutics’s (CYTO) share price is $0.3, making it a Sell.
Altamira Therapeutics’s (CYTO) 100-Day exponential moving average is 0.68, while Altamira Therapeutics’s (CYTO) share price is $0.3, making it a Sell.
Altamira Therapeutics’s (CYTO) stock price is $0.3 and Altamira Therapeutics’s (CYTO) 50-day simple moving average is 0.47, creating a Sell signal.
Altamira Therapeutics’s (CYTO) stock price is $0.3 and Altamira Therapeutics’s (CYTO) 100-day simple moving average is 0.66, creating a Sell signal.
Altamira Therapeutics’s (CYTO) stock price is $0.3 and Altamira Therapeutics’s (CYTO) 200-day simple moving average is 1.09, creating a Sell signal.

Altamira Therapeutics (CYTO) Technical Indicators

Dec 22, 2024, 10:28 PM
Name
Value
Implied Action
RSI (14)
17.81
Buy
STOCH (9,6)
1.60
Buy
STOCHRSI (14)
1.34
Buy
MACD (12,26)
-0.05
Buy
ADX (14)
28.94
Neutral
Williams %R
-95.99
Buy
CCI (14)
-445.39
Buy
ATR (14)
0.07
-
Ultimate Oscillator
17.57
Sell
ROC
-71.43
Sell
Altamira Therapeutics’s (CYTO) Relative Strength Index (RSI) is 17.81, creating a Buy signal.
Altamira Therapeutics’s (CYTO) Trend Strength Indicator (ADX) is 28.94, creating a Neutral signal.
Altamira Therapeutics’s (CYTO) Commodity Channel Index (CCI) is -445.39, creating a Buy signal.
Altamira Therapeutics’s (CYTO) Price Rate of Change (ROC) is -71.43, creating a Sell signal.

FAQ

Is CYTO a Buy, Hold, or Sell?
Based on CYTO’s technical indicators, CYTO is a Sell.
    What is CYTO’s RSI (14)?
    CYTO’s RSI (14) is 17.81, which suggests CYTO is a Buy.
      What is CYTO’s MACD?
      CYTO’s MACD is -0.05, which suggests CYTO is a Buy.
        What is CYTO’s 5-day moving average?
        CYTO’s 5-day moving average is 0.33, which suggests CYTO is a Sell.
          What is CYTO’s 20-day moving average?
          CYTO 20-day moving average is 0.42, which suggests CYTO is a Sell.
            What is CYTO’s 50-day moving average?
            CYTO’s 50-day moving average is 0.47, which suggests CYTO is a Sell.
              What is CYTO’s 200-day moving average?
              CYTO’s 200-day moving average is 1.09, which suggests CYTO is a Sell.
                What is CYTO’s Williams % R (14)?
                CYTO’s Williams % R (14) is -95.99, which suggests CYTO is a Buy.
                  What is CYTO’s CCI (14)?
                  CYTO’s CCI (14) is -445.39, which suggests CYTO is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis